First European market launch of Alvesco
Altana Pharma launches Alvesco in the United Kingdom, Launch in Germany imminent
Altana AG has announced that Alvesco® (Ciclesonide), a novel inhaled corticosteroid (ICS) for the treatment of adults (18+ years) suffering from persistent asthma is now available for the first time in the United Kingdom (UK). Altana Pharma also received the national marketing license for Germany and will start to market Alvesco® in Germany in February. Further launches will follow during the year in Europe and across the world.
More than 300 million people worldwide suffer from asthma, thereof approx. 10 million patients in the UK. IMS data indicate that the UK is the largest market in Europe for asthma medication. The market in mono-therapy inhaled corticosteroids (ICS Mono) represented a value of some EUR1 billion in 2003, of which the UK accounted for about 30 percent.
Most read news
Other news from the department research and development

Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents

Game-changing technology to remove 99% of carbon dioxide from air - Carbon capture advance could bring environmentally friendly fuel cells closer to market

UV-Consulting Peschl e.K. - Mainz, Germany

Nanomaterial safety on a nano budget - Rice University researchers share their protocol for handling carbon nanotubes

Flexible solar cells with record efficiency of 22.2% - Gaining power

Pinball at the atomic level
Oxea Announces Price Increases and 100 Percent Sales Control
Blacktrace Holdings acquires ChemiSens AB assets
